Cervical cancer is one of the most preventable cancers, yet it affects thousands of women in the U.S. each year. In 2024, an estimated 13,820 new cases and 4,360 deaths were reported. Many of these cases could have been avoided with early detection and prevention. Women of all ages are at risk, but cervical cancer most often affects those between 30 and 50 years old.
The main cause of cervical cancer is human papillomavirus (HPV), a virus so common that 80% of people will get it during their lifetime—often without knowing. While many HPV infections and pre-cancerous lesions clear up on their own, some can linger and lead to cervical cancer, particularly in women with weakened immune systems.
Vaccination is a vital way to protect yourself against cervical cancer. There are six licensed HPV vaccines, all proven safe and effective. These vaccines target HPV types 16 and 18, which cause about 70% of cervical cancer cases globally. The 9-valent vaccine, the most advanced option, provides broader protection by covering five additional HPV types linked to cervical cancer. HPV vaccination works best when given to boys and girls aged 9 to 14, before they are exposed to the virus through sexual activity. For individuals aged 15 to 26, three doses of the vaccine are recommended for full protection.
It’s important to remember that vaccination doesn’t replace regular cervical cancer screenings, such as Pap smears or HPV tests. Screenings are essential for detecting and treating pre-cancerous changes early. If you’re 21 or older, regular Pap tests can identify changes in the cervix before they progress to cancer.
Early cervical cancer often has no symptoms. Signs like unusual bleeding, pelvic pain, or discharge usually appear later when treatment is more difficult. Don’t wait for symptoms—stay proactive by getting screened and encouraging your loved ones to do the same.
By getting vaccinated, scheduling regular screenings, and staying informed, you’re taking strong steps to prevent cervical cancer. These preventative measures can significantly reduce your risk and contribute to the overall fight against cervical cancer.
About Dr. Levine
Dr. Lyuba Levine, a dual board-certified specialist at DHR Health Women’s Institute, offers expert, minimally invasive care for gynecologic cancers and complex conditions. She is dedicated to providing personalized, compassionate treatment tailored to each patient.
Dr. Lyuba Levine, DHR Health Gynecologic Oncologist
2717 Michelangelo Drive Suite 303 Edinburg, TX 78539 For more information or to speak to one of our experts, call (956) 362-2465.
